A S Saratikov Selected Research

Reye Syndrome (Reye's Syndrome)

9/2000	[Therapeutic effect of hepatoprotectors in experimental Reye syndrome].
4/2000	Experimental models of Reye's syndrome.
3/2000	[Reye's syndrome--a severe complication of salicylate therapy].
3/2000	[Effects of phospholipid hepatoprotective agents in experimental Reye syndrome].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A S Saratikov Research Topics

Disease

4	Hepatitis 03/2005 - 01/2001
4	Reye Syndrome (Reye's Syndrome) 09/2000 - 03/2000
3	Necrosis 03/2005 - 01/2001
2	Pancreatitis 07/2004 - 07/2001
2	Chronic Hepatitis (Chronic Active Hepatitis) 01/2004 - 01/2000
2	Inflammation (Inflammations) 01/2001 - 09/2000
1	Hypertension (High Blood Pressure) 01/2006
1	Chronic Hepatitis B 01/2005
1	Poisoning 07/2003
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2003
1	Intrahepatic Cholestasis 09/2002
1	Chemical and Drug Induced Liver Injury 01/2001
1	Pain (Aches) 09/2000
1	Hypoproteinemia 04/2000
1	Hypoglycemia (Reactive Hypoglycemia) 04/2000
1	Acidosis 04/2000
1	Hyperbilirubinemia 04/2000
1	Virus Diseases (Viral Diseases) 03/2000

Drug/Important Bio-Agent (IBA)

4	Carbon Tetrachloride (Tetrachloromethane)IBA 03/2005 - 01/2001
3	locheinIBA 03/2005 - 01/2000
3	BilirubinIBA 03/2005 - 01/2001
3	SilymarinIBA 03/2005 - 09/2000
3	eplirIBA 07/2004 - 01/2001
3	Phospholipids (Phosphatides)FDA LinkGeneric 07/2004 - 03/2000
3	Pharmaceutical PreparationsIBA 01/2004 - 01/2000
3	AmmoniaIBA 01/2001 - 03/2000
2	LipidsIBA 01/2006 - 03/2005
2	Transaminases (Aminotransferases)IBA 03/2005 - 07/2001
2	EnzymesIBA 07/2003 - 09/2002
2	Urea (Carbamide)FDA LinkGeneric 01/2001 - 04/2000
2	4-pentenoic acidIBA 09/2000 - 04/2000
1	CholesterolIBA 01/2006
1	Proteins (Proteins, Gene)FDA Link 03/2005
1	maksarIBA 03/2005
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2005
1	Toxic ActionsIBA 03/2005
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 03/2005
1	1-phenyl-2,3-dimethyl-4-iodopyrazoloneIBA 01/2005
1	Interferon alpha-2 (Roferon-A)FDA Link 01/2005
1	essential 303 forteIBA 07/2004
1	Ethylene Oxide (Oxirane)IBA 01/2003
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2003
1	Mixed Function Oxygenases (Monooxygenases)IBA 09/2002
1	benzobarbitalIBA 09/2002
1	halodifIBA 09/2002
1	halonalIBA 09/2002
1	Alkaline PhosphataseIBA 07/2001
1	AcidsIBA 07/2001
1	Malondialdehyde (Propanedial)IBA 01/2001
1	SoilIBA 01/2001
1	PhenolsIBA 01/2001
1	Therapeutic UsesIBA 09/2000
1	AntioxidantsIBA 09/2000
1	AntipyreticsIBA 09/2000
1	succinic acid drug combination aspirinIBA 09/2000
1	PolyphenolsIBA 09/2000
1	Ketone BodiesIBA 04/2000
1	Phenol (Carbolic Acid)FDA Link 04/2000
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2000
1	pyrogenalIBA 04/2000
1	SalicylatesIBA 03/2000
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2000

Therapy/Procedure

3	Therapeutics 01/2006 - 03/2000
1	Intraperitoneal Injections 09/2000